Assessment of clinical efficacy and tolerability of terconazole 240-mg vaginal suppositories.
D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D013488:Suppositories; D014230:Triazoles / Q000008:administration & dosage* / Q000009:adverse effects; D014621:Vagina
D000935:Antifungal Agents; D013488:Suppositories; D014230:Triazoles; C037815:terconazole